Found 7 matching trials
Study to Investigate the Absolute Bioavailability of a Single Oral Dose of Ponesimod in Healthy Male Subjects PHASE1 This study consists of a single-dose pilot phase and a randomized, two-way ...
Show More Location
Simbec Research Limited
Learn More & Join Trial
Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of Ponesimod in Subjects With Symptomatic Chronic GVHD PHASE2 Chronic graft versus host diseasre (GVHD) is a serious reaction that might ...
Show More Location
Multiple Locations
Learn More & Join Trial
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial NA FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) tar...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Treatments Being Tested
Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsq Glatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod Learn More & Join Trial
Clinical Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Ponesimod in Patients With Relapsing-remitting Multiple Sclerosis PHASE2 This study is an extension to the study AC-058B201 and will investigate the...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of the Electrocardiographic Effects of Ponesimod in Healthy Male and Female Subjects PHASE1 The aim of this study is to demonstrate that therapeutic and supratherapeut...
Show More Location
Covance Clinical Research Unit (CRU)
Learn More & Join Trial
Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-128800 in Healthy Subjects PHASE1 This was a single-center, randomized, double-blind, placebo-controlled, up-...
Show More Location
Quintiles Drug Research Unit at Guy's Hospital
Learn More & Join Trial
Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis PHASE2 This study will assess the efficacy, safety, and tolerability of ACT-128800...
Show More Location
Clinical Investigative Site 3132
Learn More & Join Trial